Tango Therapeutics Inc. is a pioneering clinical-stage biotechnology company dedicated to transforming cancer treatment with its innovative focus on synthetic lethality and targeted therapies. The company's extensive pipeline features a range of promising drug candidates aimed at precision oncology, positioning it as a key player in the field. By forging strategic collaborations with leading academic institutions, Tango enhances its research capabilities and strengthens its commitment to addressing significant unmet needs in cancer care. Through its forward-thinking approach, Tango…